Techindia Nirman Limited has informed the Exchange about change in Management
Awaiting price reaction for this filing.
Techindia Nirman Limited has informed the stock exchanges that two Independent Directors have stepped down from the board after completing their first term. Mr. Vadla Nagabhushanam ceased to be an Independent Director effective October 30, 2025, and Mr. Madhukar Dhondiraj Deshpande ceased effective February 12, 2026. Both directors were also on the board of Nath Bio-Genes (India) Limited and served on key committees such as Audit, Stakeholders Relationship, and Nomination & Remuneration at Techindia. The company noted that this disclosure was delayed because the company was under CIRP (Corporate Insolvency Resolution Process) during the cessation period. The CFO, Mr. Sunil Dixit, signed the filing.
The exits are routine completions of fixed-term tenures and not resignations, so the immediate impact on the stock should be limited. However, the mention of CIRP proceedings is a red flag for shareholders, as the company is undergoing insolvency resolution, which could materially affect equity value and recovery prospects.